MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 27 filers reported holding MOLECULIN BIOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,123 | -26.4% | 14,305 | -0.5% | 0.00% | – |
| Q2 2023 | $8,323 | +69258.3% | 14,374 | +16.6% | 0.00% | – |
| Q1 2023 | $12 | +100.0% | 12,329 | +130.2% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 5,355 | -45.2% | 0.00% | – |
| Q3 2022 | $10,000 | +66.7% | 9,772 | +133.8% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 4,180 | -0.3% | 0.00% | – |
| Q1 2022 | $7,000 | – | 4,191 | +10377.5% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 40 | -98.4% | 0.00% | – |
| Q2 2021 | $9,000 | – | 2,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,040,529 | $1,852,000 | 0.61% |
| Sigma Planning Corp | 57,500 | $102,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 4,233 | $7,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,650 | $12,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,176 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 50,731 | $90,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 245,612 | $437,000 | 0.00% |
| STATE STREET CORP | 71,397 | $127,000 | 0.00% |
| North Star Investment Management Corp. | 250 | $0 | 0.00% |